James G. Coulter, 10% Owner at Trevi Therapeutics, Inc. (TRVI), sold 23,434 shares at $2.77 ($65K) on 2022-04-28, disclosed to the SEC on 2022-05-02.
Open-market sale of $65k TRVI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.77 | 7,271 | $20K | 31.2% |
| 2 | $2.75 | 16,163 | $44K | 68.8% |
| Total | $2.76 avg | 23,434 | $65K | 100% |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateTPG Twin Brook Capital Income Fund | BUY | 2025-12-30 | $100.0M | — | Filing → |
| SION | BUY |
| 2025-07-01 |
| $950K |
| — |
| Filing → |
| TPG | SELL | 2024-02-29 | $109.7M | — | Filing → |
| SLGG | SELL | 2023-08-17 | $3.4M | — | Filing → |
| SLGG | SELL | 2023-07-28 | $38K | — | Filing → |